Since 1 January 2025, it has been officially permitted in Denmark to have highly specialised single-use medical devices reprocessed. To make it easier for hospitals to adopt this practice, financial support has been introduced: DKK 0.5 million in 2025, DKK 1.5 million...
At the heart of the article is the work of our Research and Development (R&D) department, which ensures that all processes within Medical Remanufacturing comply with regulatory requirements – including the EU Medical Device Regulation (MDR), the Implementing...
That’s why Vanguard AG is now sponsoring an agroforestry system. This year, the innovative agricultural company Gut&Bösel, together with the Finck Foundation, established an agrosilvopastoral agroforestry system spanning 26,5 hectares, featuring nearly 8...
Soundstar® Ultrasound Catheter Four versions of the Soundstar® ultrasound mapping catheter with 3D mapping functionality are now available as CS-certified reprocessed products: Farastar Catheter Connection Cable The Farastar Catheter Connection Cable from Boston...
Between Legacy and Innovation: Digital Transformation in Medical Device Reprocessing Balancing stability and innovation is not a contradiction – at Vanguard, it is part of daily operations. This team stands out precisely because of its ability to master this balancing...
On 30 June 2025, the previous CE reprocessing and placing on the market was discontinued. Since July, these catheters have been reprocessed exclusively under contract reprocessing (CS), in accordance with Article 17(3) to (5) of Regulation (EU) 2017/745 (MDR). The...
